SHR-RAS001
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
Discovery and identification of SHR-RAS001: A structurally novel, highly potent tri-complex RASmulti(ON) inhibitor
(AACR 2026)
- "Abstract is embargoed at this time."
Late-breaking abstract • Oncology
1 to 1
Of
1
Go to page
1